Patrick Henning to lead CLSA’s Federal, State and Local Government Relations, Communications, Policy and Alliance Development Efforts on behalf of California’s life sciences sector
House overwhelmingly passes year-end spending deal that includes a permanent repeal of the 2.3% medical device tax, Senate likely to approve
CLSA Disappointed by House Passage of H.R. 3, Legislation That Will Short-Circuit Treatments for Patients and California Innovation
California leads the world in life sciences innovation. Premier research institutions combine with a unique entrepreneurial spirit to develop new technologies and therapies, attract investors and push the state’s economy to greater heights. It’s critical that we protect this pioneering activity to continue bringing hope to patients everywhere. See the highlights from our 2019 California Life Sciences Industry Report.
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, today announced the expansion of its board of directors, adding three new members. Joining the board are: Mohit Trikha, Ph.D., Vice President, Head of Oncology Early Development & AbbVie Bay Area Site Head; Lesley Stolz, Ph.D., Managing Director, Lasana Partners; and Grace Han McMahon, Head of Transactions, Pacific Innovation Hub, Business Development & Licensing, Merck Research Laboratories.
California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, invites members of the press to attend the 2019 CLSA Pantheon DiNATM Awards, a distinguished program that honors and recognizes the impact that California’s therapeutic, diagnostic, medical device, and industrial biotechnology companies are making in California and for patients around the globe
CLSA and Biocom Release Data Showing Anticipated Real-World Impact of Foreign Reference Pricing Proposed by House Democrats in H.R. 3 to Lower Drug Prices
Life Sciences Trade Groups Warn Congress: International Reference Pricing Proposals Included in Bills like H.R. 3 Undermine Hope for Patients and America’s Leadership in Biomedical Innovation
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, has announced that Dr. Jennifer Doudna, a visionary leader in CRISPR gene editing technology and nominee for Nobel Prize in Chemistry, will receive the 2019 Life Sciences Leadership Award, a prestigious award to be presented at CLSA’s 2019 Pantheon DiNA Program. The Pantheon Awards honors California’s most innovative and dedicated life sciences leaders for their ongoing contributions to California’s life sciences sector.
California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, has announced the 2019 Pantheon DiNATM Awards slate of honorees. Through the premier awards program, CLSA annually recognizes excellence in the California life sciences sector and celebrates the contributions and achievements of leading life sciences innovators in the state.